Kimberly J Hwa1, Monica M Dua2, Sherry M Wren1,2, Brendan C Visser1,2. 1. Department of Surgery, Palo Alto Veterans Affairs, Palo Alto, CA, USA. 2. Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Abstract
BACKGROUND: Socioeconomic disparities in patients with hepatocellular carcinoma (HCC) influence medical treatment. In addition to socioeconomic barriers, the Veteran population suffers from significant psychosocial obstacles. This study identifies the social challenges that Veterans face while undergoing treatment for HCC. METHODS: One hundred Veterans at the Palo Alto VA treated for HCC from 2009 to 2014 (50 consecutive patients who underwent a surgical procedure; 50 treated with intra-arterial therapy) were retrospectively reviewed. RESULTS: Substance abuse history was identified in 96%, and half were unemployed. Most patients survived on a limited income [median $1340, interquartile range (IQR) 900-2125]; 36% on ≤ $1000/month, 37% between $1001-2000/month and 27% with >$2000/month. A history of homelessness was found in 30%, more common in those of the lowest income (57% of ≤$1K/month group, 23% of $1-2K/month group and 9% of >$2K/month group, P < 0.01). Psychiatric illness was present in 64/100 patients; among these the majority received ongoing psychiatric treatment. Transportation was provided to 23% of patients who would otherwise have been unable to attend medical appointments. CONCLUSIONS: Psychiatric disease and substance abuse are highly prevalent among Veterans with HCC. Most patients survive on a very meager income. These profound socioeconomic and psychosocial problems must be recognized when providing care for HCC to this population to provide adequate treatment and surveillance.
BACKGROUND: Socioeconomic disparities in patients with hepatocellular carcinoma (HCC) influence medical treatment. In addition to socioeconomic barriers, the Veteran population suffers from significant psychosocial obstacles. This study identifies the social challenges that Veterans face while undergoing treatment for HCC. METHODS: One hundred Veterans at the Palo Alto VA treated for HCC from 2009 to 2014 (50 consecutive patients who underwent a surgical procedure; 50 treated with intra-arterial therapy) were retrospectively reviewed. RESULTS:Substance abuse history was identified in 96%, and half were unemployed. Most patients survived on a limited income [median $1340, interquartile range (IQR) 900-2125]; 36% on ≤ $1000/month, 37% between $1001-2000/month and 27% with >$2000/month. A history of homelessness was found in 30%, more common in those of the lowest income (57% of ≤$1K/month group, 23% of $1-2K/month group and 9% of >$2K/month group, P < 0.01). Psychiatric illness was present in 64/100 patients; among these the majority received ongoing psychiatric treatment. Transportation was provided to 23% of patients who would otherwise have been unable to attend medical appointments. CONCLUSIONS:Psychiatric disease and substance abuse are highly prevalent among Veterans with HCC. Most patients survive on a very meager income. These profound socioeconomic and psychosocial problems must be recognized when providing care for HCC to this population to provide adequate treatment and surveillance.
Authors: Fatma M Shebl; David E Capo-Ramos; Barry I Graubard; Katherine A McGlynn; Sean F Altekruse Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-06-05 Impact factor: 4.254
Authors: Dirk Bausch; Ulrich Wellner; Sebastian Kahl; Simon Kuesters; Hans-Jürgen Richter-Schrag; Stefan Utzolino; Ulrich T Hopt; Tobias Keck; Andreas Fischer Journal: Surgery Date: 2012-07-06 Impact factor: 3.982
Authors: Sanjat Kanjilal; Edward W Gregg; Yiling J Cheng; Ping Zhang; David E Nelson; George Mensah; Gloria L A Beckles Journal: Arch Intern Med Date: 2006-11-27
Authors: Jessica A Davila; Louise Henderson; Jennifer R Kramer; Fasiha Kanwal; Peter A Richardson; Zhigang Duan; Hashem B El-Serag Journal: Ann Intern Med Date: 2011-01-18 Impact factor: 25.391
Authors: Stanley D Rosenberg; Jeffrey W Swanson; George L Wolford; Fred C Osher; Marvin S Swartz; Susan M Essock; Marian I Butterfield; Bryan J Marsh Journal: Psychiatr Serv Date: 2003-06 Impact factor: 3.084
Authors: Nathaniel Jembere; Michael A Campitelli; Morris Sherman; Jordan J Feld; Wendy Lou; Stuart Peacock; Eric Yoshida; Murray D Krahn; Craig Earle; Hla-Hla Thein Journal: PLoS One Date: 2012-07-13 Impact factor: 3.240
Authors: Joanna L Martin; Desiree R Azizoddin; Lauren Z Rynar; Jane Weber; Tyra Oliver; Christine B Weldon; Joshua M Hauser Journal: Fed Pract Date: 2021-08
Authors: Patricio M Polanco; Michelle R Ju; Matthieu Chansard; M Mathew Augustine; Jennie Meier; Eric Mortensen; Herbert J Zeh; Adam C Yopp Journal: Ann Surg Oncol Date: 2022-05-22 Impact factor: 4.339